Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Monique Wapenaar-deKorver (Vlaardingen, Netherlands), Monique Wapenaar-deKorver, Amit S. Patel, Surinder S. Birring, Juanita A. Haagsma, Marlies S. Wijsenbeek. Comparison of changes of the King’s brief interstitial lung disease questionnaire (K-BILD) with other health status measures. Eur Respir J 2016; 48: Suppl. 60, 790

Member's Comments

No comment yet.

Related content which might interest you: Quality of life measures in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Response of the King’s brief interstitial lung disease (KBILD) questionnaire to pulmonary rehabilitation (PR) Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity Year: 2015 A comparison of two scoring methods for the King’s brief interstitial lung disease questionnaire Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Quality of life in interstitial lung disease: Utility of the Kings brief interstitial lung disease questionairre at baseline Source: International Congress 2015 – New insights into IIPs Year: 2015 The King’s brief interstitial lung disease (K-BILD) questionnaire; an updated minimal important difference Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Health status & impact of living with idiopathic pulmonary fibrosis (IPF): UK & Ireland Delphi survey Source: International Congress 2016 – IPF clinical Year: 2016 Item generation for a patient reported outcome measure (PRoM) in idiopathic pulmonary fibrosis (IPF): Application of consensus methods Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry Source: International Congress 2016 – IPF clinical Year: 2016 A longitudinal study of anxiety and depression in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Impact of gender on disease activity, pulmonary function and health status in sarcoidosis patients – King’s sarcoidosis questionnaire (KSQ) Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Depression and anxiety in pulmonary fibrosis: A pilot study Source: International Congress 2015 – IPF: clinical aspects Year: 2015 A comparison of two scoring methods for the King’s sarcoidosis questionnaire Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us? Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 The physical and psychological needs of patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 The efficacy of a walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). A pilot study Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Quality of life of idiopathic pulmonary fibrosis patients Source: Eur Respir J 2001; 17: 954-961 Year: 2001 The lived experience of idiopatic pulmonary fibrosis: A qualitative study Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences Year: 2016 The burden of idiopathic pulmonary fibrosis reported by patients and carers in Ireland Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Assessment of nutritional status in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016